Simona Kormanikova News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Simona Kormanikova. Real-time updates on events, politics, business and more.

Daré Bioscience Announces Executive Team and Board of

January 26, 2024

SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced changes in...

San Diego United States San Diego State University Sabrina Martucci Johnson Simona Kormanikova Camilla White

Source: globenewswire.com

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

December 26, 2023

SAN DIEGO, Dec. 26, 2023 -- Daré Bioscience, Inc. , a leader in women’s health innovation, today announced it has entered into a royalty-backed financing agreement that provides Daré with $5...

United States San Diego Sabrina Martucci Johnson Camilla White Simona Kormanikova Exchange Commission

Source: marketscreener.com

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study - Dare Bioscience (NASDAQ:DARE)

December 13, 2023

DARE-PTB1 is being developed as a treatment to reduce the risk of preterm birth, for which there are no FDA-approved treatment options Up to approximately $2 million in grant funding to support DARE-PTB1 Phase 1 human

United States San Diego Sabrina Martucci Johnson Simona Kormanikova Camilla White Human Development

Source: benzinga.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Simona Kormanikova News Today

Dare&#x301; Bioscience Announces Executive Team and Board of

Dar&#xE9; Bioscience Secures $12 million in Royalty-backed Investment Structure

Dar&#xE9; Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study - Dare Bioscience (NASDAQ:DARE)

Explore More Categories

Daré Bioscience Announces Executive Team and Board of

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study - Dare Bioscience (NASDAQ:DARE)